COMMUNITY
The following start-ups
are part of our community
2024
2023
2022
2021
2020
2019
2018
Limula
Transforming cancer treatment: Limula’s revolutionary automation technology for personalized cell therapies.
Limula strives to “bring these breathtaking personalized cell therapies to all of the eligible patients”. They are leading the way in making a new type of cancer treatments accessible, by automating the manufacturing of CAR T and other cell therapies.
Co-Founders Luc Henry (CEO), Thomas Eaton (COO) and Yann Pierson (CTO) speak in their testimonial video about their commitment to meeting the rising demand for cutting-edge biotechnological solutions, as Limula continues to grow, expand its team, and refine its technology.
Reconnect Labs
Pioneering Regenerative Therapeutics for mental health, revolutionizing psychiatric treatment
Reconnect Labs develops Regenerative Therapeutics™ for mental health as breakthrough-therapies for difficult to treat psychiatric conditions.
Co-Founder and CEO, Davor Kosanic and Co-Founder and CSO, Dario Dornbierer speak in the film about their mission to regenerate mental and ecosystem health.
MUVON Therapeutics
Isolated and multiplied muscle stem cells prevent urinary incontinence
MUVON Therapeutics develops an autologous cell therapy platform for the treatment of diseases related to skeletal muscle damage or degradation. Their goal is to help millions of patients suffering from stress urinary incontinence to regain control over their life by offering them minimally invasive, low-risk treatments for the regeneration of skeletal muscle tissue.
Co-Founder and CEO of MUVON Therapeutics, Deana Mohr, speaks in her testimonial about her mission to establish personalized, regenerative treatments as the primary standard of care.
InterAx
Mathematical system engineering in cells helps to find affordable treatments for all
InterAx accelerates drug discovery with systems Biology and Artificial Intelligence. Their breakthrough platform combines systems biology, pharmacology, and artificial intelligence to accelerate the hit-to-lead process in GPCR drug discovery.
Co-Founder of InterAx, Gebhard Schertler and Co-Founder and CEO, Auélien Rizk, speak in their testimonial video about their mission to develop a pharmacology that is affordable.
Microcaps
Tailored formulations made for precise microencapsulation
Microcaps makes sure that drugs are released in the affected part of the body and at a specific rate. Since the size of the capsules that deliver these active ingredients is uncontrollable, they developed a patented technology that enables the size control of these microcapsules with Swiss precision.
Co-Founders and Co-CEOs of Microcaps, Alessandro Ofner and Michael Hagander, speak in their testimonial video about their mission to develop formulations that can bring as much benefit to as many customers as possible.
Hylomorph
An even more carefree life for people with implants
Hylomorph aims at minimizing post-surgical complications in medical implants, thus improving patients’ quality-of-life and reducing associated healthcare costs. They are specialized in the cutting-edge combination of micro-engineering and biotechnology applied to innovative biomaterials for healthcare products.
Co-Founder and CEO of Hylomorph, Simone Bottan, speaks in his testimonial video about his mission to shift the focus for patients towards a holistic approach.
Synendos
Fundamental new treatment for neuropsychiatric disorders
Synendos Therapeutics is a biopharmaceutical company that aims to develop breakthrough safe and effective therapies for unmet needs in neuropsychiatric disorders through modulation of a new drug target in the endocannabinoid system that enables restoration of natural functioning of the brain.
Co-Founder and CEO of Synendos Therapeutics, Andrea Chicca, speaks in his testimonial video about his mission to develop further human medicine.
Artidis
Imagine future cancer diagnoses with almost no waiting
ARTIDIS rapidly diagnoses cancer, detects its aggressiveness, and predicts the probability of a patient developing metastases based on the nanomechanical biomarker for cancer.
Co-Founder and CEO of ARTIDIS, Marija Plodinec, speaks in her testimonial video about her mission to revolutionize cancer diagnosis.
Biospectal
Control your blood pressure with any smartphone
Biospectal is making instant, ubiquitous, and accurate remote blood pressure monitoring and management a reality. By placing a finger on the smartphone camera, anyone can transform their phone into a medical grade blood pressure monitor including data integration with the clinical care regimen – any time, anywhere in the world.
Co-Founder and Chief Medical Advisor of Biospectal, Patrick Schoettker, speaks in his testimonial video about his mission to improve management of care.
CUTISS
Lose rigid scars with your own new growing skin
Cutiss is an innovative, Swiss life-science company aiming to provide patients that suffer from large and deep skin defects with the first automate-produced, personalized skin tissue therapy, denovoSkin™ - a safe, effective and accessible therapy for children and adults.
Founder and CEO of Cutiss, Daniela Marino, speaks in her testimonial video about her mission to treat skin defects.
T3 Pharma
When programmable bacteria fight against tumours
T3 Pharmaceuticals is a pre-clinical biopharmaceutical company working to advance new generation therapies for cancer patients. Its dedicated team is developing highly specific and efficient treatments using live bacteria.
Co-Founder and CEO of T3 Pharmaceuticals, Simon Ittig, speaks in his testimonial video about his mission to fight tumours.
